Rachel Bergmans1, Amr S Soliman, Julie Ruterbusch, Rafael Meza, Kelly Hirko, John Graff, Kendra Schwartz. 1. Rachel Bergmans is with the Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor. Amr S. Soliman is with the Department of Epidemiology, University of Nebraska Medical Center College of Public Health, Omaha. Julie Ruterbusch is with the Department of Oncology, Wayne State School of Medicine, Detroit, MI. Rafael Meza and Kelly Hirko are with the Department of Epidemiology, University of Michigan School of Public Health. John Graff is with the New Jersey Registry, SEER Registry, Trenton. Kendra Schwartz is with Family Medicine and Public Health Sciences, Wayne State University School of Medicine.
Abstract
OBJECTIVES: We calculated cancer incidence for Arab Americans in California; Detroit, Michigan; and New Jersey, and compared rates with non-Hispanic, non-Arab Whites (NHNAWs); Blacks; and Hispanics. METHODS: We conducted a study using population-based data. We linked new cancers diagnosed in 2000 from the Surveillance, Epidemiology, and End Results Program (SEER) to an Arab surname database. We used standard SEER definitions and methodology for calculating rates. Population estimates were extracted from the 2000 US Census. We calculated incidence and rate ratios. RESULTS: Arab American men and women had similar incidence rates across the 3 geographic regions, and the rates were comparable to NHNAWs. However, the thyroid cancer rate was elevated among Arab American women compared with NHNAWs, Hispanics, and Blacks. For all sites combined, for prostate and lung cancer, Arab American men had a lower incidence than Blacks and higher incidence than Hispanics in all 3 geographic regions. Arab American male bladder cancer incidence was higher than that in Hispanics and Blacks in these regions. CONCLUSIONS: Our results suggested that further research would benefit from the federal recognition of Arab Americans as a specified ethnicity to estimate and address the cancer burden in this growing segment of the population.
OBJECTIVES: We calculated cancer incidence for Arab Americans in California; Detroit, Michigan; and New Jersey, and compared rates with non-Hispanic, non-Arab Whites (NHNAWs); Blacks; and Hispanics. METHODS: We conducted a study using population-based data. We linked new cancers diagnosed in 2000 from the Surveillance, Epidemiology, and End Results Program (SEER) to an Arab surname database. We used standard SEER definitions and methodology for calculating rates. Population estimates were extracted from the 2000 US Census. We calculated incidence and rate ratios. RESULTS: Arab American men and women had similar incidence rates across the 3 geographic regions, and the rates were comparable to NHNAWs. However, the thyroid cancer rate was elevated among Arab American women compared with NHNAWs, Hispanics, and Blacks. For all sites combined, for prostate and lung cancer, Arab American men had a lower incidence than Blacks and higher incidence than Hispanics in all 3 geographic regions. Arab American male bladder cancer incidence was higher than that in Hispanics and Blacks in these regions. CONCLUSIONS: Our results suggested that further research would benefit from the federal recognition of Arab Americans as a specified ethnicity to estimate and address the cancer burden in this growing segment of the population.
Authors: Minah Kang-Kim; Joseph R Betancourt; John Z Ayanian; Alan M Zaslavsky; Recai M Yucel; Joel S Weissman Journal: Med Care Date: 2008-05 Impact factor: 2.983
Authors: N Al-Hamdan; K Ravichandran; J Al-Sayyad; J Al-Lawati; Z Khazal; F Al-Khateeb; A Abdulwahab; A Al-Asfour Journal: East Mediterr Health J Date: 2009 May-Jun Impact factor: 1.628
Authors: Suzanne Havstad; Alexandra R Sitarik; Christine Cole Johnson; Edward M Zoratti; Dennis R Ownby; Albert M Levin; Ganesa Wegienka Journal: Ann Allergy Asthma Immunol Date: 2017-09-20 Impact factor: 6.347